Open the mobile version, with barcode scanning
Class II Ongoing

Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose Vials, Rx only, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-286-23; N…

Why: Presence of Particulate Matter: Hair was found in products

Company
Fresenius Kabi USA, LLC
Lake Zurich, IL, United States
Reported
Jul 29, 2026
Recall started
Jul 16, 2026
Where sold
Nationwide within in the USA
Amount
92,600 vials
Full product description
Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose Vials, Rx only, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-286-23; NDC Vial: 63323-286-05
Lots / codes affected
Lot #: 6133436, Exp. Date 10/2028

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.